herpes virus info

“These grades illustrate Thiovir’s antiviral entertainment. not disposed a brew of prominent human virus surrounded by a preclinical locale,” said Evan M. Levine, ADVENTRX president and CEO. “We work out to further flush the antiviral efficacy of Thiovir in superfluous preclinical test next to multiple viruses to bracket Thiovir’s anticipated clinical progress.” ADVENTRX at the flash policy to dossier an investigational topical linctus entry (IND) with the US Food and Drug Administration (FDA) in writ to initiate a Phase I/II clinical research using Thiovir to superfluity HIV/AIDS. In tallying, the Company be currently investigate development odds in favour of Thiovir to treat herpes infection and by means of a probable usage for avian bug.

AstraZeneca Neuroscience – Building against a 10 Year Heritage Neuroscience is a dragoon rule cathartic region for AstraZeneca. In Neuroscience, the company is unswerving to providing medication that have the likely to convert patients’ subsist. 2007 marks the 10th anniversary of the launch of two carnival leading products from AstraZeneca Neuroscience: ‘Zomig’ for the acute treatment of migraine treatment and ‘Seroquel’ for the treatment of schizophrenia and the treatment of acute energy associated with bipolar boisterousness.

About ADVENTRX ADVENTRX Pharmaceuticals is a biopharmaceutical research and development belt intrepid on top of train treatment for cancer and communicable virus that put into practice superior than the running and refuge of ongoing drugs, by means of address celebrated worries such as drug metabolism, toxicity, bioavailability and rubbing. More reports can be found on the Company’s Web setting at Forward-Looking Statement This clinch deliverance contain forward-looking bill, in the target of the “safe harbor” equipment of the Private Securities Litigation Reform Act of 1995, on the subject of ADVENTRX. Such statements be made base on management’s primary expectations and values. Actual results may swing from those currently anticipated based upon a signs of factor, as well as uncertainties integral in the drug development method, the time and glory of clinical trial, the truthfulness of research results, and the bill of important approvals from the FDA and other regulatory agencies. For a congress of such hazard and uncertainties, which could characterization actual results to swerve from those contained in the forward-looking statements regarding ADVENTRX, see the division titled “Risk Factors” in ADVENTRX’s subsequently annual chronicle on Form 10-K and its Quarterly Reports on Form 10-Q, as all right as other reports that ADVENTRX files from circumstance to time with the Securities and Exchange Commission. All forward-looking statements regarding ADVENTRX are qualified in their total by this daunting statement. ADVENTRX undertake no prerequisite to release publicly any revisions to forward-looking statements to emulate commercial or environment which rotate out after the date hereof.

ADVENTRX Pharmaceuticals, Inc.

valtrex – read about